Terms: = Sarcomas AND APOBEC3B, ARP4, 9582, ENSG00000179750, DJ742C19_2, _phorbolin 3_, PHRBNL, FLJ21201, Q9UH17, bK150C2_2, APOBEC1L, ARCD3 AND Prognosis
4275 results:
1. Correlations between the modification patterns mediated by pyroptosis-related genes, tumor microenvironment, and immunotherapy in soft tissue sarcoma.
Cai Y; Meng J; Qiu Y; Huang X; Du H; Yao J
Medicine (Baltimore); 2024 May; 103(20):e38173. PubMed ID: 38758862
[TBL] [Abstract] [Full Text] [Related]
2. Osteosarcoma After Total Knee Arthroplasty: A Case Report.
Martínez-Collado P; Pujol O; Bustos A; Plomer M; Carrasco MG; Silva T; Vélez R; Minguell J
JBJS Case Connect; 2024 Apr; 14(2):. PubMed ID: 38728527
[TBL] [Abstract] [Full Text] [Related]
3. p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL Expression.
Komatsubara T; Tazawa H; Hasei J; Omori T; Sugiu K; Mochizuki Y; Demiya K; Yoshida A; Fujiwara T; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Acta Med Okayama; 2024 Apr; 78(2):151-161. PubMed ID: 38688833
[TBL] [Abstract] [Full Text] [Related]
4. Targeting KRAS in pancreatic cancer.
Stickler S; Rath B; Hamilton G
Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
[TBL] [Abstract] [Full Text] [Related]
5. Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway.
Zhu Y; Yang L; Yu Y; Xiong Y; Xiao P; Fu X; Luo X
Oncol Res; 2024; 32(5):899-910. PubMed ID: 38686047
[TBL] [Abstract] [Full Text] [Related]
6. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].
Yuan Q; Han YL; Pan C; Tang JY; Gao YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):365-370. PubMed ID: 38660900
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of circ_0076684 in osteosarcoma facilitates malignant processes by mediating miRNAs/CUX1.
Cai P; Fu X; Li X; Zhao W
J Orthop Surg Res; 2024 Apr; 19(1):260. PubMed ID: 38659042
[TBL] [Abstract] [Full Text] [Related]
9. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract] [Full Text] [Related]
10. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
11. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
12. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract] [Full Text] [Related]
13. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
Wu Y; Yang J; Xu G; Chen X; Qu X
BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
[TBL] [Abstract] [Full Text] [Related]
14. Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
Hudhud L; Rozmer K; Kecskés A; Pohóczky K; Bencze N; Buzás K; Szőke É; Helyes Z
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612571
[TBL] [Abstract] [Full Text] [Related]
15. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.
Liao Z; Teng J; Li T; Liu H; Li T; Zhang C; Xing R; Teng S; Yang Y; Zhao J; Xiao W; Zhang G; Li MJ; Yao W; Yang J
Front Immunol; 2024; 15():1292325. PubMed ID: 38585276
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
[TBL] [Abstract] [Full Text] [Related]
18. Sirolimus combined with glucocorticoids in the treatment of Kasabach-Merritt phenomenon in a neonate: A case report.
Cheng J; Zou Y; Fu R; Jin P; Huang M; Wu Z; Bai H; Huang X; Yuan H
Medicine (Baltimore); 2024 Apr; 103(14):e37706. PubMed ID: 38579031
[TBL] [Abstract] [Full Text] [Related]
19. Radical resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma-A pilot study in a tertiary Asian centre.
Seo CJ; Tan JW; Farid M; Wong JSM; Soo KC; Chia CS; Ong CJ
PLoS One; 2024; 19(4):e0300594. PubMed ID: 38574044
[TBL] [Abstract] [Full Text] [Related]
20. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
Cao J; Zhu C; Cao Z; Ke X
Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
[TBL] [Abstract] [Full Text] [Related]
[Next]
